Hematology News

Although the insertion of inferior vena cava filters declined between 2013 and 2021, the rate of retrievals remained low, according to a study published in JAMA.

In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exhibition, which examined Factor V Leiden and prothrombin mutation and the risk for venous thromboembolism.

In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exposition, which examined the risk of thrombosis in patients with a protein S deficiency.

In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exhibition, which further probed the potential comorbidities in patients with a factor XII deficiency.

In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exposition, which examined the use of obinutuzumab in patients with thrombotic thrombocytopenic purpura.

An increasing number of gene therapies correct genetic disorders, including hemoglobinopathies.

In this video, Ronak Mistry, DO, discusses the results of a study presented at ASH Annual Meeting that examined the use of hydroxyurea in patients with hemoglobin SC disease.

In this video, Ronak Mistry, DO, discusses the results of a study presented at ASH Annual Meeting that examined the use of the Bruton tyrosine kinase inhibitor rilzabrutinib in patients with immune thrombocytopenic purpura.

In this video, Amy Dickey, MD, MSc, discusses a study presented at ASH Annual Meetingthat examined treatment of Diamond-Blackfan anemia with bitopertin.